Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 277 to 285 of 285 entries
Sorted by: Best Match Show Resources per page
Human TH1 and TH2 Subsets.

International archives of allergy and immunology

Romagnani S, Del Prete G, Maggi E, Parronchi P, De Carli M, Macchia D, Manetti R, Sampognaro S, Piccinni MP, Giudizi MG, Biagiotti R, Almerigogna F.
PMID: 34167205
Int Arch Allergy Immunol. 1992;99(2):242-245. doi: 10.1159/000236257. Epub 2009 Sep 02.

Human CD4+ T cell clones secreting different patterns of cytokines similar to TH1 and TH2 cells described in mice have been demonstrated. These human TH1 and TH2 clones are produced in response to different antigens and exhibit distinct functional...

Cite
Romagnani S, Del Prete G, Maggi E, et al. Human TH1 and TH2 Subsets. Int Arch Allergy Immunol. 2009;99(2):242-245doi: 10.1159/000236257.
Romagnani, S., Del Prete, G., Maggi, E., Parronchi, P., De Carli, M., Macchia, D., Manetti, R., Sampognaro, S., Piccinni, M. P., Giudizi, M. G., Biagiotti, R., & Almerigogna, F. (1992). Human TH1 and TH2 Subsets. International archives of allergy and immunology, 99(2), 242-245. https://doi.org/10.1159/000236257
Romagnani, Sergio, et al. "Human TH1 and TH2 Subsets." International archives of allergy and immunology vol. 99,2 (1992): 242-245. doi: https://doi.org/10.1159/000236257
Romagnani S, Del Prete G, Maggi E, Parronchi P, De Carli M, Macchia D, Manetti R, Sampognaro S, Piccinni MP, Giudizi MG, Biagiotti R, Almerigogna F. Human TH1 and TH2 Subsets. Int Arch Allergy Immunol. 1992;99(2):242-245. doi: 10.1159/000236257. Epub 2009 Sep 02. PMID: 34167205.
Copy Download .nbib Format: NLM
The impact of the prolonged COVID-19 pandemic on stress resilience and mental health: A critical review across waves.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology

Manchia M, Gathier AW, Yapici-Eser H, Schmidt MV, de Quervain D, van Amelsvoort T, Bisson JI, Cryan JF, Howes OD, Pinto L, van der Wee NJ, Domschke K, Branchi I, Vinkers CH.
PMID: 34818601
Eur Neuropsychopharmacol. 2021 Oct 29;55:22-83. doi: 10.1016/j.euroneuro.2021.10.864. Epub 2021 Oct 29.

The global public health crisis caused by COVID-19 has lasted longer than many of us would have hoped and expected. With its high uncertainty and limited control, the COVID-19 pandemic has undoubtedly asked a lot from all of us....

Cite
Manchia M, Gathier AW, Yapici-Eser H, et al. The impact of the prolonged COVID-19 pandemic on stress resilience and mental health: A critical review across waves. Eur Neuropsychopharmacol. 2021;55:22-83doi: 10.1016/j.euroneuro.2021.10.864.
Manchia, M., Gathier, A. W., Yapici-Eser, H., Schmidt, M. V., de Quervain, D., van Amelsvoort, T., Bisson, J. I., Cryan, J. F., Howes, O. D., Pinto, L., van der Wee, N. J., Domschke, K., Branchi, I., & Vinkers, C. H. (2021). The impact of the prolonged COVID-19 pandemic on stress resilience and mental health: A critical review across waves. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 5522-83. https://doi.org/10.1016/j.euroneuro.2021.10.864
Manchia, Mirko, et al. "The impact of the prolonged COVID-19 pandemic on stress resilience and mental health: A critical review across waves." European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology vol. 55 (2021): 22-83. doi: https://doi.org/10.1016/j.euroneuro.2021.10.864
Manchia M, Gathier AW, Yapici-Eser H, Schmidt MV, de Quervain D, van Amelsvoort T, Bisson JI, Cryan JF, Howes OD, Pinto L, van der Wee NJ, Domschke K, Branchi I, Vinkers CH. The impact of the prolonged COVID-19 pandemic on stress resilience and mental health: A critical review across waves. Eur Neuropsychopharmacol. 2021 Oct 29;55:22-83. doi: 10.1016/j.euroneuro.2021.10.864. Epub 2021 Oct 29. PMID: 34818601; PMCID: PMC8554139.
Copy Download .nbib Format: NLM
Early Postnatal Genistein Administration Affects Mice Metabolism and Reproduction in a Sexually Dimorphic Way.

Metabolites

Marraudino M, Ponti G, Moussu C, Farinetti A, Macchi E, Accornero P, Gotti S, Collado P, Keller M, Panzica G.
PMID: 34357343
Metabolites. 2021 Jul 10;11(7). doi: 10.3390/metabo11070449.

The phytoestrogen genistein (GEN) may interfere with permanent morphological changes in the brain circuits sensitive to estrogen. Due to the frequent use of soy milk in the neonatal diet, we aimed to study the effects of early GEN exposure...

Cite
Marraudino M, Ponti G, Moussu C, et al. Early Postnatal Genistein Administration Affects Mice Metabolism and Reproduction in a Sexually Dimorphic Way. Metabolites. 2021;11(7)doi: 10.3390/metabo11070449.
Marraudino, M., Ponti, G., Moussu, C., Farinetti, A., Macchi, E., Accornero, P., Gotti, S., Collado, P., Keller, M., & Panzica, G. (2021). Early Postnatal Genistein Administration Affects Mice Metabolism and Reproduction in a Sexually Dimorphic Way. Metabolites, 11(7), . https://doi.org/10.3390/metabo11070449
Marraudino, Marilena, et al. "Early Postnatal Genistein Administration Affects Mice Metabolism and Reproduction in a Sexually Dimorphic Way." Metabolites vol. 11,7 (2021). doi: https://doi.org/10.3390/metabo11070449
Marraudino M, Ponti G, Moussu C, Farinetti A, Macchi E, Accornero P, Gotti S, Collado P, Keller M, Panzica G. Early Postnatal Genistein Administration Affects Mice Metabolism and Reproduction in a Sexually Dimorphic Way. Metabolites. 2021 Jul 10;11(7). doi: 10.3390/metabo11070449. PMID: 34357343; PMCID: PMC8303179.
Copy Download .nbib Format: NLM
An Intensive Educational Intervention Significantly Improves the Adoption of Single Fractionation Radiotherapy in Uncomplicated Bone Metastases.

Clinical Medicine Insights. Oncology

Donati CM, Nardi E, Galietta E, Alfieri ML, Siepe G, Zamagni A, Buwenge M, Macchia G, Deodato F, Cilla S, Strigari L, Cammelli S, Cellini F, Morganti AG.
PMID: 34366683
Clin Med Insights Oncol. 2021 Jul 22;15:11795549211027148. doi: 10.1177/11795549211027148. eCollection 2021.

INTRODUCTION: An education strategy was employed in our department to increase the rate of patients with uncomplicated painful bone metastases undergoing single fractionation radiotherapy (SFRT). The purpose of this report is to analyze the results of this strategy over...

Cite
Donati CM, Nardi E, Galietta E, et al. An Intensive Educational Intervention Significantly Improves the Adoption of Single Fractionation Radiotherapy in Uncomplicated Bone Metastases. Clin Med Insights Oncol. 2021;15:11795549211027148doi: 10.1177/11795549211027148.
Donati, C. M., Nardi, E., Galietta, E., Alfieri, M. L., Siepe, G., Zamagni, A., Buwenge, M., Macchia, G., Deodato, F., Cilla, S., Strigari, L., Cammelli, S., Cellini, F., & Morganti, A. G. (2021). An Intensive Educational Intervention Significantly Improves the Adoption of Single Fractionation Radiotherapy in Uncomplicated Bone Metastases. Clinical Medicine Insights. Oncology, 1511795549211027148. https://doi.org/10.1177/11795549211027148
Donati, Costanza M, et al. "An Intensive Educational Intervention Significantly Improves the Adoption of Single Fractionation Radiotherapy in Uncomplicated Bone Metastases." Clinical Medicine Insights. Oncology vol. 15 (2021): 11795549211027148. doi: https://doi.org/10.1177/11795549211027148
Donati CM, Nardi E, Galietta E, Alfieri ML, Siepe G, Zamagni A, Buwenge M, Macchia G, Deodato F, Cilla S, Strigari L, Cammelli S, Cellini F, Morganti AG. An Intensive Educational Intervention Significantly Improves the Adoption of Single Fractionation Radiotherapy in Uncomplicated Bone Metastases. Clin Med Insights Oncol. 2021 Jul 22;15:11795549211027148. doi: 10.1177/11795549211027148. eCollection 2021. PMID: 34366683; PMCID: PMC8312156.
Copy Download .nbib Format: NLM
CB1 receptor binding sites for NAM and PAM: A first approach for studying, new n‑butyl‑diphenylcarboxamides as allosteric modulators.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences

Gado F, Ceni C, Ferrisi R, Sbrana G, Stevenson LA, Macchia M, Pertwee RG, Bertini S, Manera C, Ortore G.
PMID: 34863873
Eur J Pharm Sci. 2021 Dec 01;169:106088. doi: 10.1016/j.ejps.2021.106088. Epub 2021 Dec 01.

The development of cannabinoid receptor type-1 (CB1R) modulators has been implicated in multiple pathophysiological events ranging from memory deficits to neurodegenerative disorders among others, even if their central psychiatric side effects such as depression, anxiety, and suicidal tendencies, have...

Cite
Gado F, Ceni C, Ferrisi R, et al. CB1 receptor binding sites for NAM and PAM: A first approach for studying, new n‑butyl‑diphenylcarboxamides as allosteric modulators. Eur J Pharm Sci. 2021;169:106088doi: 10.1016/j.ejps.2021.106088.
Gado, F., Ceni, C., Ferrisi, R., Sbrana, G., Stevenson, L. A., Macchia, M., Pertwee, R. G., Bertini, S., Manera, C., & Ortore, G. (2021). CB1 receptor binding sites for NAM and PAM: A first approach for studying, new n‑butyl‑diphenylcarboxamides as allosteric modulators. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 169106088. https://doi.org/10.1016/j.ejps.2021.106088
Gado, Francesca, et al. "CB1 receptor binding sites for NAM and PAM: A first approach for studying, new n‑butyl‑diphenylcarboxamides as allosteric modulators." European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences vol. 169 (2021): 106088. doi: https://doi.org/10.1016/j.ejps.2021.106088
Gado F, Ceni C, Ferrisi R, Sbrana G, Stevenson LA, Macchia M, Pertwee RG, Bertini S, Manera C, Ortore G. CB1 receptor binding sites for NAM and PAM: A first approach for studying, new n‑butyl‑diphenylcarboxamides as allosteric modulators. Eur J Pharm Sci. 2021 Dec 01;169:106088. doi: 10.1016/j.ejps.2021.106088. Epub 2021 Dec 01. PMID: 34863873.
Copy Download .nbib Format: NLM
Sustained symptomatic remission in schizophrenia: Course and predictors from a two-year prospective study.

Schizophrenia research

Carpiniello B, Pinna F, Manchia M, Tusconi M, Cavallaro R, Bosia M.
PMID: 34839071
Schizophr Res. 2021 Nov 25;239:34-41. doi: 10.1016/j.schres.2021.11.023. Epub 2021 Nov 25.

BACKGROUND: Although remission is a priority target in psychosis, reported rates show a marked variation across studies and instability over time. Such variability, partly due to methodology, emphasizes the need to define the optimal assessment procedure, as well as...

Cite
Carpiniello B, Pinna F, Manchia M, et al. Sustained symptomatic remission in schizophrenia: Course and predictors from a two-year prospective study. Schizophr Res. 2021;239:34-41doi: 10.1016/j.schres.2021.11.023.
Carpiniello, B., Pinna, F., Manchia, M., Tusconi, M., Cavallaro, R., & Bosia, M. (2021). Sustained symptomatic remission in schizophrenia: Course and predictors from a two-year prospective study. Schizophrenia research, 23934-41. https://doi.org/10.1016/j.schres.2021.11.023
Carpiniello, Bernardo, et al. "Sustained symptomatic remission in schizophrenia: Course and predictors from a two-year prospective study." Schizophrenia research vol. 239 (2021): 34-41. doi: https://doi.org/10.1016/j.schres.2021.11.023
Carpiniello B, Pinna F, Manchia M, Tusconi M, Cavallaro R, Bosia M. Sustained symptomatic remission in schizophrenia: Course and predictors from a two-year prospective study. Schizophr Res. 2021 Nov 25;239:34-41. doi: 10.1016/j.schres.2021.11.023. Epub 2021 Nov 25. PMID: 34839071.
Copy Download .nbib Format: NLM
Incidence of Pneumothorax and Pneumomediastinum in 497 COVID-19 Patients with Moderate-Severe ARDS over a Year of the Pandemic: An Observational Study in an Italian Third Level COVID-19 Hospital.

Journal of clinical medicine

Tetaj N, Garotto G, Albarello F, Mastrobattista A, Maritti M, Stazi GV, Marini MC, Caravella I, Macchione M, De Angelis G, Busso D, Di Lorenzo R, Scarcia S, Farina A, Centanni D, Vargas J, Savino M, Carucci A, Antinori A, Palmieri F, D'Offizi G, Ianniello S, Taglietti F, Campioni P, Vaia F, Nicastri E, Girardi E, Marchioni L, Icu Covid-Study Group.
PMID: 34884310
J Clin Med. 2021 Nov 29;10(23). doi: 10.3390/jcm10235608.

(1) Background: COVID-19 is a novel cause of acute respiratory distress syndrome (ARDS). Indeed, with the increase of ARDS cases due to the COVID-19 pandemic, there has also been an increase in the incidence of cases with pneumothorax (PNX)...

Cite
Tetaj N, Garotto G, Albarello F, et al. Incidence of Pneumothorax and Pneumomediastinum in 497 COVID-19 Patients with Moderate-Severe ARDS over a Year of the Pandemic: An Observational Study in an Italian Third Level COVID-19 Hospital. J Clin Med. 2021;10(23)doi: 10.3390/jcm10235608.
Tetaj, N., Garotto, G., Albarello, F., Mastrobattista, A., Maritti, M., Stazi, G. V., Marini, M. C., Caravella, I., Macchione, M., De Angelis, G., Busso, D., Di Lorenzo, R., Scarcia, S., Farina, A., Centanni, D., Vargas, J., Savino, M., Carucci, A., Antinori, A., Palmieri, F., D'Offizi, G., Ianniello, S., Taglietti, F., Campioni, P., Vaia, F., Nicastri, E., Girardi, E., Marchioni, L., & Icu Covid-Study Group. (2021). Incidence of Pneumothorax and Pneumomediastinum in 497 COVID-19 Patients with Moderate-Severe ARDS over a Year of the Pandemic: An Observational Study in an Italian Third Level COVID-19 Hospital. Journal of clinical medicine, 10(23), . https://doi.org/10.3390/jcm10235608
Tetaj, Nardi, et al. "Incidence of Pneumothorax and Pneumomediastinum in 497 COVID-19 Patients with Moderate-Severe ARDS over a Year of the Pandemic: An Observational Study in an Italian Third Level COVID-19 Hospital." Journal of clinical medicine vol. 10,23 (2021). doi: https://doi.org/10.3390/jcm10235608
Tetaj N, Garotto G, Albarello F, Mastrobattista A, Maritti M, Stazi GV, Marini MC, Caravella I, Macchione M, De Angelis G, Busso D, Di Lorenzo R, Scarcia S, Farina A, Centanni D, Vargas J, Savino M, Carucci A, Antinori A, Palmieri F, D'Offizi G, Ianniello S, Taglietti F, Campioni P, Vaia F, Nicastri E, Girardi E, Marchioni L, Icu Covid-Study Group. Incidence of Pneumothorax and Pneumomediastinum in 497 COVID-19 Patients with Moderate-Severe ARDS over a Year of the Pandemic: An Observational Study in an Italian Third Level COVID-19 Hospital. J Clin Med. 2021 Nov 29;10(23). doi: 10.3390/jcm10235608. PMID: 34884310.
Copy Download .nbib Format: NLM
Project Last Mile and the development of the Girl Champ brand in eSwatini: engaging the private sector to promote uptake of health services among adolescent girls and young women.

SAHARA J : journal of Social Aspects of HIV/AIDS Research Alliance

Brault MA, Christie S, Aquino S, Rendin A, Manchia A, Curry LA, Linnander EL.
PMID: 33685358
SAHARA J. 2021 Dec;18(1):52-63. doi: 10.1080/17290376.2021.1894224.

In eSwatini and across sub-Saharan Africa, adolescent girls and young women (AGYW) are at significantly higher risk of HIV infection and poorer sexual and reproductive health (SRH) than their male counterparts. AGYW demonstrate low demand for SRH services, further...

Cite
Brault MA, Christie S, Aquino S, et al. Project Last Mile and the development of the Girl Champ brand in eSwatini: engaging the private sector to promote uptake of health services among adolescent girls and young women. SAHARA J. 2021;18(1):52-63doi: 10.1080/17290376.2021.1894224.
Brault, M. A., Christie, S., Aquino, S., Rendin, A., Manchia, A., Curry, L. A., & Linnander, E. L. (2021). Project Last Mile and the development of the Girl Champ brand in eSwatini: engaging the private sector to promote uptake of health services among adolescent girls and young women. SAHARA J : journal of Social Aspects of HIV/AIDS Research Alliance, 18(1), 52-63. https://doi.org/10.1080/17290376.2021.1894224
Brault, Marie A, et al. "Project Last Mile and the development of the Girl Champ brand in eSwatini: engaging the private sector to promote uptake of health services among adolescent girls and young women." SAHARA J : journal of Social Aspects of HIV/AIDS Research Alliance vol. 18,1 (2021): 52-63. doi: https://doi.org/10.1080/17290376.2021.1894224
Brault MA, Christie S, Aquino S, Rendin A, Manchia A, Curry LA, Linnander EL. Project Last Mile and the development of the Girl Champ brand in eSwatini: engaging the private sector to promote uptake of health services among adolescent girls and young women. SAHARA J. 2021 Dec;18(1):52-63. doi: 10.1080/17290376.2021.1894224. PMID: 33685358; PMCID: PMC7946024.
Copy Download .nbib Format: NLM
Sustained symptomatic remission in schizophrenia: Course and predictors from a two-year prospective study.

Schizophrenia research

Carpiniello B, Pinna F, Manchia M, Tusconi M, Cavallaro R, Bosia M.
PMID: 34839071
Schizophr Res. 2022 Jan;239:34-41. doi: 10.1016/j.schres.2021.11.023. Epub 2021 Nov 25.

BACKGROUND: Although remission is a priority target in psychosis, reported rates show a marked variation across studies and instability over time. Such variability, partly due to methodology, emphasizes the need to define the optimal assessment procedure, as well as...

Cite
Carpiniello B, Pinna F, Manchia M, et al. Sustained symptomatic remission in schizophrenia: Course and predictors from a two-year prospective study. Schizophr Res. 2021;239:34-41doi: 10.1016/j.schres.2021.11.023.
Carpiniello, B., Pinna, F., Manchia, M., Tusconi, M., Cavallaro, R., & Bosia, M. (2022). Sustained symptomatic remission in schizophrenia: Course and predictors from a two-year prospective study. Schizophrenia research, 23934-41. https://doi.org/10.1016/j.schres.2021.11.023
Carpiniello, Bernardo, et al. "Sustained symptomatic remission in schizophrenia: Course and predictors from a two-year prospective study." Schizophrenia research vol. 239 (2022): 34-41. doi: https://doi.org/10.1016/j.schres.2021.11.023
Carpiniello B, Pinna F, Manchia M, Tusconi M, Cavallaro R, Bosia M. Sustained symptomatic remission in schizophrenia: Course and predictors from a two-year prospective study. Schizophr Res. 2022 Jan;239:34-41. doi: 10.1016/j.schres.2021.11.023. Epub 2021 Nov 25. PMID: 34839071.
Copy Download .nbib Format: NLM
Showing 277 to 285 of 285 entries